Please assess the completion status of the following clinical trial:

Trial Title: Management of Asthma Patients Guided by Exhaled Nitric Oxide (eNO)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Pre-existing diagnosis of asthma~* Persistent, moderate or severe asthma as classified by NAEPP~* Sub-optimally controlled asthma~* Initiated ICS therapy for at least the past 30 days and a history of improvement of asthma control on steroids~Exclusion Criteria:~* Active cigarette smoking or ≥ 10 pack-years smoking history~* Xolair taken in the past 6 months prior to enrollment~* Oral prednisone taken in the last 4 weeks prior to enrollment~* Cystic Fibrosis, COPD, ciliary dyskinesia, chest wall deformities or scoliosis~* Subject is currently enrolled in another investigational drug study

- Gender: ALL
- Minimum Age: 12 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- eNO group (Type: ACTIVE_COMPARATOR): eNO measurement is used to inform asthma management decisions
- control group (Type: NO_INTERVENTION): Asthma is managed according to existing standard of care

Based on this trial design, predict the completion outcome and termination type (if applicable).